Malondialdehyde-acetaldehyde haptenated protein binds macrophage scavenger receptor(s) and induces lysosomal damage.
There is evidence that the chemical modification of proteins (haptens) with malondialdehyde-acetaldehyde (MAA) and the immune response to these haptenated proteins is associated with the initiation and/or progression of alcohol liver disease. Experimentally, proteins modified with MAA induce antibody and T cell responses, which are mediated by scavenger receptor(s). Moreover, macrophages have been shown to play an important role in processing and presenting MAA-haptenated proteins in vitro. In vitro, MAA-modified proteins have been shown to induce both apoptosis and necrosis in a dose- and cell-type-dependent manner. Natural ligands modified by oxidative stress, such as oxidized LDL, similarly initiate not only antibody responses, but also cause cell death by disrupting lysosomes after binding to scavenger receptors and internalization. We therefore investigated the binding, internalization, and lysosomal integrity in a macrophage cell line to a MAA-haptenated protein. We demonstrate for the first time that MAA-haptenated proteins are preferentially bound by scavenger receptors on macrophages, which internalize the ligands and shuttle them to lysosomes. Moreover, MAA-haptenated proteins are demonstrated to be associated with a rapid dose-dependent disruption in lysosomal integrity, resulting in leakage and caspase activation. Similarly, as hen egg lysozyme (HEL)-MAA concentrations increased (>31.3 microg/ml), increased levels of apoptosis and a G1/S cell cycle checkpoint inhibition were identified. This study identifies mechanisms by which MAA-haptenated proteins are taken up by a representative antigen-presenting cell and may delineate steps by which MAA-haptenated proteins induce cell death and induce their immunogenicity to the carrier protein.
Willis
Monte S
MS
Department of Internal Medicine, University of Nebraska Medical Center, 983025 Nebraska Medical Center, Omaha, NE 68198-3025, USA. montewillis@juno.com
Klassen
Lynell W
LW
Carlson
Deborah L
DL
Brouse
Chad F
CF
Thiele
Geoffrey M
GM
D000079:Acetaldehyde / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D053148:Caspase 3; D020169:Caspases / Q000096:biosynthesis; D002453:Cell Cycle / Q000187:drug effects; D016923:Cell Death / Q000187:drug effects; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D006241:Haptens / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D008247:Lysosomes / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D008315:Malondialdehyde / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D009113:Muramidase / Q000276:immunology; D011485:Protein Binding; D011971:Receptors, Immunologic / Q000276:immunology*; D051116:Receptors, Scavenger
D006241:Haptens; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D008315:Malondialdehyde; C421864:hen egg lysozyme; D009113:Muramidase; D053148:Caspase 3; D020169:Caspases; D000079:Acetaldehyde